These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8188446)

  • 21. Progress in group A streptococcal vaccine development.
    Kotloff KL; Dale JB
    Pediatr Infect Dis J; 2004 Aug; 23(8):765-6. PubMed ID: 15295227
    [No Abstract]   [Full Text] [Related]  

  • 22. Outbreak of invasive group A streptococcal disease in two hospitals, Ontario, 2003.
    Nolan L; Schertzberg R; Wilson-Clark S; McGeer A; Pellizzari R; Steingart C
    Can Commun Dis Rep; 2008 Apr; 34(4):8-19. PubMed ID: 18800411
    [No Abstract]   [Full Text] [Related]  

  • 23. Group A streptococcal vaccines.
    Dale JB
    Infect Dis Clin North Am; 1999 Mar; 13(1):227-43, viii. PubMed ID: 10198801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.
    O'Loughlin RE; Roberson A; Cieslak PR; Lynfield R; Gershman K; Craig A; Albanese BA; Farley MM; Barrett NL; Spina NL; Beall B; Harrison LH; Reingold A; Van Beneden C;
    Clin Infect Dis; 2007 Oct; 45(7):853-62. PubMed ID: 17806049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid core peptide technology and group A streptococcal vaccine delivery.
    Olive C; Batzloff MR; Toth I
    Expert Rev Vaccines; 2004 Feb; 3(1):43-58. PubMed ID: 14761243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress toward a global group a streptococcal vaccine.
    Steer AC; Dale JB; Carapetis JR
    Pediatr Infect Dis J; 2013 Feb; 32(2):180-2. PubMed ID: 23328823
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunoprophylaxis of streptococcal infections in suckling piglets--testing of a streptococcal-staphylococcal adsorbate vaccine for vaccination of sows in advanced pregnancy].
    Schöll W; Bernhard J; Köhler B; Senf W; Zabke J; Glaser F; Barbe J
    Arch Exp Veterinarmed; 1983 Jul; 37(4):511-26. PubMed ID: 6651439
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.
    Bisno AL; Rubin FA; Cleary PP; Dale JB;
    Clin Infect Dis; 2005 Oct; 41(8):1150-6. PubMed ID: 16163634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoid thyroiditis following immunization with group A streptococcal vaccine.
    Tonooka N; Leslie GA; Greer MA; Olson JC
    Am J Pathol; 1978 Sep; 92(3):681-90. PubMed ID: 356626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive group A streptococcal infections in children.
    Davies HD; Schwartz B
    Adv Pediatr Infect Dis; 1999; 14():129-45. PubMed ID: 10079852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology and prevention of streptococcal infections].
    Ivan A; Groll M; Buzdugan I; Mitroi I
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):61-5. PubMed ID: 2814031
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relationship of streptococcal infection to rheumatism].
    Rotta J
    Vopr Revm; 1976; (4):8-10. PubMed ID: 799399
    [No Abstract]   [Full Text] [Related]  

  • 34. [The return of serious infections caused by Streptococcus pyogenes].
    Maclaren DM
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1318-9. PubMed ID: 8345889
    [No Abstract]   [Full Text] [Related]  

  • 35. Progress towards developing a vaccine for group A streptococcus based on the M protein.
    Good MF
    Intern Med J; 2002 Apr; 32(4):132-3. PubMed ID: 11951921
    [No Abstract]   [Full Text] [Related]  

  • 36. Uncovering the mysteries of invasive streptococcal diseases.
    Chhatwal GS; McMillan DJ
    Trends Mol Med; 2005 Apr; 11(4):152-5. PubMed ID: 15823752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inequitable burden of group A streptococcal diseases in Indigenous Australians.
    May PJ; Bowen AC; Carapetis JR
    Med J Aust; 2016 Sep; 205(5):201-3. PubMed ID: 27581260
    [No Abstract]   [Full Text] [Related]  

  • 38. StreptAvax (ID Biomedical).
    McMillan D
    Curr Opin Investig Drugs; 2006 Feb; 7(2):186-90. PubMed ID: 16499290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus.
    Batzloff MR; Yan H; Davies MR; Hartas J; Lowell GH; White G; Burt DS; Leanderson T; Good MF
    J Infect Dis; 2005 Oct; 192(8):1450-5. PubMed ID: 16170764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing epidemiology of acute rheumatic fever in the United States.
    Lee GM; Wessels MR
    Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.